cases is difficult. Grade 4 could be considered pure ICH, pure IVH, or one of these plus some measurement of subarachnoid clot. 8, 25 Therefore, a quantitative method of measuring subarachnoid clot might improve our ability to predict vasospasm.
A second issue of interest from a clinical and scientific perspective is that other features of the clot may be important contributors to the development of vasospasm. These include clot density 37 and the rate of clot clearance. 6, 19 Although several neurosurgeons have investigated the role of these factors in relation to vasospasm, there are no studies in which the relationships between vasospasm and initial clot volume, clearance, and density have been examined simultaneously and quantitatively. Because larger volumes of clot might clear more slowly, a multivariate analysis would be needed to determine whether clot volume and clearance are independent factors associated with vasospasm. mean age of the 75 patients studied was 51 Ϯ 14 years; 55 patients (73%) were female. These patients were identified from a prospectively collected database that included the medical and radiological information necessary for the study apart from the specific quantitative imaging data. The 75 patients who were included had undergone a noninfused cranial CT scan obtained on the day of SAH and at least one CT scan that was obtained days later. Only patients with SAH that was visible on admission CT scans were included. Patients were excluded if the admission CT scan was of poor quality, not obtained within 24 hours of SAH, or was unavailable. Treatment with Guglielmi Detachable Coils and SAH secondary to arteriovenous malformation, head injury, or other identifiable nonaneurysm cause led to exclusion from the study. Patients who underwent coil treatment were excluded because the large posttreatment imaging artifact made it impossible to quantify subarachnoid clot. All patients were treated in a neurological intensive care unit. We performed TCD ultrasonography every other day and all patients received nimodipine orally. Clinical deterioration was investigated using CT scanning and other modalities as necessary. All patients received at least 3.5 L/day of intravenous fluid and if clinical deterioration occurred because of vasospasm, more fluids were administered and blood pressure was elevated pharmacologically.
All available medical records and neuroimaging studies were reviewed and information was collected on factors known or suggested to be important in the genesis of vasospasm. Data retrieved included age, sex, history of hypertension, smoking status, admission GCS score 41 , WFNS grade 9 , Hunt and Hess 21 grade, and Fisher grade 12 on admission CT scans. Patients with Fisher Grade 1 were excluded, Grade 2 was assigned to patients in whom the clot thickness was less than 3 mm in actual size on axial CT images obtained on admission, Grade 3 was assigned to patients with clots thicker than this, and Grade 4 to those with only IVH. The IVH was measured on a semiquantitative scale in which each ventricle (lateral, third, and fourth) was categorized as follows: 0, no blood; 1, layers of blood in the dependent part of the ventricle; 2, moderately filled; and 3, completely filled. This scale led to scores ranging from 0 to 12.
5 Intraventricular hemorrhage was coded "yes" for scores greater than 5. The subarachnoid blood was determined based on the Fisher grade; a patient with thick subarachnoid and intraventricular clots was assigned to Grade 3. Because of the potential nonlinearity of the effects of variables on vasospasm, age by decade was entered as a continuous or as a categorical variable.
Outcome was assessed at 1 to 6 months after SAH by using the modified Rankin Scale and the Glasgow Outcome Scale. 22 Assessments were made by the senior author (R.L.M.) at outpatient clinic visits. Although the investigators were not specifically blinded to the Fisher grade on admission CT scans or to whether the patient suffered vasospasm, assessments would be unlikely to be systematically biased because they were performed before this study was conceived and without detailed review of each patient's admission CT scan and hospital course.
Definition of Vasospasm
Symptomatic vasospasm was defined by the following combined clinical and radiological criteria: 1) onset of confusion, disorientation, and/or decline in level of consciousness with or without focal deficit(s) 5 to 12 days after SAH; 2) a head CT scan excluding other causes of neurological worsening such as hydrocephalus, intracranial hemorrhage, and/or focal brain swelling; 3) no other identifiable cause of neurological worsening such as electrolyte disturbance, hypoxia, or seizures; and 4) confirmation of vasospasm on angiographic or TCD ultrasonography studies. 16 Neurological worsening due to vasospasm was defined as a decrease in the modified GCS score 23 of 2 points or a 2-point increase in the motor score on the National Institutes of Health Stroke Scale that lasted for 8 or more hours. 4 The definition of vasospasm included patients in whom the following factors applied: 1) CT scans did not demonstrate infarction but the patient experienced the aforementioned syndrome; 2) evidence of vasospasm was demonstrated on angiographic (Ͼ 50% reduction in diameter of a major cerebral artery) or TCD studies (mean middle cerebral artery flow velocity 200 cm/second or more 4 to 14 days after SAH) in the absence of clinical symptoms; and 3) new infarcts were present on CT scans that were not observed on immediate postoperative scans and no cause other than vasospasm was possible. The senior author reviewed the clinical course and radiological data available in every patient when this information was entered into the database and prior to the writing of this report to determine whether vasospasm, as defined here, had occurred.
Radiological Variables
Radiological features entered into the analysis were clot thickness on admission CT scans graded according to the Fisher scale and the presence or absence of IVH hemorrhage as described earlier. Computerized tomography scans from the University of Chicago (admission scans and 52 postadmission scans) were available in a lossless raw data format from the DICOM storage system (Kodak 9410 picture archiving and communication system; Eastman Kodak, Rochester, NY). All scans that were available digitally were analyzed in their original format, scaled to Level 15/Window 100 (Ϫ15 to 85 HU) in a Floating Point image DICOM browser (version 0.05). The DICOM header was stripped after exporting the patient number, study date, millimeters per pixel, and slice thickness. Slice thickness was calculated from the distance between scans and was almost always 7 mm on CT scans obtained at the University of Chicago. The CT scans obtained at other institutions (admission and no postadmission scans) and those unavailable in the DICOM format (31 admission and 23 postadmission scans) were digitized using a laser scanner (version 4.7.0, LUMISYS model LS75; Eastman Kodak). Only films on which a distance standard was printed on each slice were used. There were 24 admission CT scans available for density measurement. Hounsfield units for density analysis were not standardized or used with scanned films because density values for known scans available through DICOM never matched the estimated values for laser-scanned images; the difference in blood density between scans was minimal (Ͻ 15 HU in general) and irregularities in printing and scanning were routinely encountered. These irregularities had no impact on volume measurements because each slice was standardized to its adjacent distance marker.
After all CT studies were digitized, each slice contain-ing part of the basal cisterns was analyzed for thickness of blood clot. Subarachnoid hemorrhage over the convexities was ignored because in previous reports it has never been shown that it is important in the genesis of vasospasm.
13,14
The method differed slightly for native and scanned digital images. Native images were exported from Floating Point Image to Adobe Photoshop (version 7.0; Adobe Systems, Inc., San Jose, CA). Density was calibrated to the same range that the image had when displayed in Floating Point Image by using the IPTK (version 4.0; Reindeer Graphics, Asheville, NC) to calibrate the density function. A single examiner blinded to the clinical data and results of other CT scans then broadly and manually selected the entire region of interest. Nonblood hyperdense areas such as bone were manually subtracted from the region of interest and the region was then modified by clicking the mouse on a hyperdense blood area and using the subtracting wand of the IPTK. If the selection was judged to be accurate-it included subarachnoid blood and blood from no other areas-the pixel number and density in the selected area were quantified using the IPTK measuring function. If the selection did not include only subarachnoid blood, the range of the wand tool was changed and the selection was repeated until the examiner found the best position possible for the blood clot in that slice. The output text file resulting from this process was imported into Microsoft Excel (version XP; Microsoft Corp., Redmond, WA), in which program the total number of selected pixels was multiplied by the millimeters per pixel squared and the calculated slice thickness to yield a volume. Density was recorded as the mean of all selected pixels. The process was repeated for each CT slice that included the basal cisterns. All slice volumes were summed and all densities were averaged. Density was weighted by the number of pixels each slice represented, resulting in a single volume and density for each study. Stored CT scans were analyzed in similar fashion with a few modifications. Without altering leveling, the scans were imported into Photoshop by using the program XnView (version 1.37; Pierre E. Gougelet, Reims, France). Density values were not standardized or included in the study for these patients. Each CT slice was calibrated for millimeters per pixel within Photoshop by using the distance guide adjacent to the image (usually an 8-to 12-cm bar) and the IPTK to calibrate the distance function. Most images included a horizontal and a vertical guide. As a check of the CT data, the ratio of width to height was calculated on these images and uniformly found to be 1:1. The subarachnoid clot then was selected as described earlier. Volume was calculated by multiplying the number of selected pixels by the area per pixel (as given by the calibrated IPTK measure function) and by the slice thickness. Slice thickness was recorded by the examiner after calculating the distance between slices for each study.
One challenge to the method of blood selection defined earlier was the presence of clip artifacts on almost all of the 67 CT scans obtained subsequent to the admission studies. Most scans exhibited clip artifact on one slice. If there was no subarachnoid blood clot on the slice above or below the one containing the clip artifact and there was no substantial clot visible outside the area of artifact on the slice that contained it, the study was considered to have 0 clot volume. If there was blood visible in any of these unaffected areas, it was quantified using the technique described earlier. All clip artifacts were removed manually. No blood was assumed to be present in the area of clip artifact if the following conditions were met: 1) the region was completely inaccessible because the clip was relatively small and by definition could not itself contain blood; 2) the area where the clip was inserted was necessarily one that was surgically accessible and therefore most commonly had a marked reduction in subarachnoid clot after surgery; and 3) the hyperdensity caused by the clip artifact was likely to cause a slight increase in the measurement of blood around it, despite the best efforts of the examiner to minimize such increases.
Statistical Analysis
Initial scans were recorded as Day 0 and the number of days from the initial scan was calculated for all subsequent ones analyzed (mean 3.8 Ϯ 2.8 days, range 1-16 days, 56 patients with one, 18 with three, and one with four postadmission scans analyzed). Each Day 0 scan provided the initial clot volume and density. The final study analyzed was used to measure the final volume and total time in days. A variety of factors relating to clot clearance were examined to account for the possibility that clearance rates were nonlinear or were related in some way to the initial clot volume. Log transforms of some variables were studied to see whether the relationship between vasospasm and clot volume might resemble a pharmacological dose-response curve in which this volume is best expressed logarithmically. Clearance volume was calculated as the initial minus final volume and clearance amount per day was clearance volume divided by time between scans in days. Similarly, the percentage of clot cleared was calculated by dividing the cleared amount by the initial amount and the percentage cleared per day was calculated by dividing the percentage cleared by time between scans. All percentages were limited to 0 to 100 because small changes in patients with very little blood (for example, Ͻ 2 ml) on the initial scan occasionally resulted in highly negative values for percentage of clot cleared, as noted by Brouwers, et al. 6 Comparisons of each variable between patients with and without vasospasm was made by using the Chi-square and Student t-tests.
The primary question asked at the outset of this study was: what factors are associated with development of vasospasm? Vasospasm was treated as the dependent variable and as dichotomous (present or absent) throughout the study and the variables identified earlier that were potentially associated with vasospasm were analyzed using logistic regression models (version 8.2; SAS, Cary, NC). Univariate analysis of each variable was performed before beginning the selection process. Dummy variables based on quartiles were used to assess the assumption of linearity for continuous variables such as patient age, initial clot volume, and clot clearance rates and percentages. Univariate logistic regression modeling was then used to obtain the estimated coefficient, estimated standard error, likelihood ratio test for significance of the coefficient, and the univariate Wald statistic. Statistically significant variables (p Ͻ 0.1 both to enter and to stay in analysis) in the simple logistic regressions were then entered into multivariate logistic models by using stepwise selection, forward selection, and backward elimination procedures. The significance of each variable included in the model was verified using the Wald statistic. The overall fit was then assessed between several different models by using the likelihood ratio test. Unadjusted and adjusted odds ratios and 95% confidence intervals for occurrence of vasospasm were derived from the logistic regression models. Tests for interaction were conducted between each variable entered into the multivariate models and the study indicator variable. Finally, a composite variable of initial volume and percentage of clot cleared per day was determined by examining the distribution of the study population and by using a scatterplot diagram. Data are given as mean Ϯ standard deviation.
Results
Clinical grade, aneurysm location, Fisher grade, and treatment factors are shown in Table 1 . Overall, vasospasm developed in 26 patients (35%). The mean initial clot volume was 10.4 Ϯ 8.7 ml (range 0.2-38 ml) and the mean volume of clot cleared per day was 2.8 Ϯ 3.5 ml (range 0-21 ml). The mean percentage of clot cleared per day was 28 Ϯ 18% (range 0Ϫ92%). Comparison of these values between patients with and without vasospasm showed no significant difference in mean values between groups. Tests of linearity showed that for age, the rate of vasospasm was highest for patients 40 to 59 years of age, suggesting an inverted U-shaped relationship between age and vasospasm. Therefore, in the logistic regression analysis, age was entered both as a continuous and as a categorical variable by decile. For initial clot volume the relationship was linear with larger clot volumes associated with a greater likelihood of vasospasm, whereas for clot clearance in milliliters per day the relationship was relatively flat, with similar odds of vasospasm regardless of clearance. The percentage of clot cleared per day, however, showed decreasing odds of vasospasm with increasing amounts of clot cleared per day.
Univariate analysis was conducted first and showed that vasospasm was significantly associated with Fisher grade, initial clot volume, and the percentage of clot cleared per day (Table 2 and Fig. 1 ). Vasospasm was more likely with Fisher Grade 3, higher initial clot volume, and lower percentage of clot cleared per day. The total volume of clot cleared was of marginal significance and was entered into the multivariate models along with those factors that were significant. Multivariate models were constructed using these factors and stepwise logistic regression showed that vasospasm was associated with initial clot volume and the percentage of clot cleared per day (Table 3 ). The most parsimonious and stable model created using multiple variables in both forward and backward logistic regression included only these variables. It is notable that clot volume cleared per day and total clot cleared were highly dependent on the initial clot volume, whereas percentage of clot cleared per day was not.
Close examination of the relationship between initial clot volume and the risk of vasospasm indicated that the relationship was nonlinear, exhibiting a saturating trend with higher clot volumes. This relationship is reminiscent of a pharmacological action or a dose-response curve of initial clot volume and vasospasm. Thus, performing a log transformation of the initial clot volume will result in a linear relationship between initial clot volume and risk of vasospasm (Fig. 2) . Composite variables were derived from the multivariate equations by using the original and log-transformed clot volumes, in which clot volumes were classified into 3 categories (Ͻ 1 ml, 1-10 ml, Ͼ 10 ml). The transformation leads to a more significant composite variable for * ACA = anterior cerebral artery; adm = admission; ICA = internal carotid artery; MCA = middle cerebral artery; occl = occlusion; pst = posterior. prediction of vasospasm and to improved clustering of vasospasm risk; these results are demonstrated by scatterplots (Fig. 3) .
Initial clot density measurements were available in 24 patients (four with vasospasm and 20 without). Only a univariate analysis could be conducted. Higher initial clot density and younger age were significantly related to vasospasm (p Յ 0.05).
Discussion
Few investigators have used image analysis to quantify subarachnoid clot volumes. 3 Friedman, et al., 14 reported a method of quantification of SAH and noted that volumes more than 20 ml were highly likely to be associated with delayed ischemic neurological deficits. The new findings in this study are the identification, using multivariate analysis, of the independent predictive power of purely quantitative measurements of subarachnoid clot volume, density, and clearance rate for vasospasm after SAH.
Experimental studies of vasospasm are widely believed to have shown that the volume of blood injected or placed into the subarachnoid space of animals as well as the time that it remains there are important factors that influence the severity and duration of vasospasm. 30 This assumption, however, has seldom been tested systematically. Furthermore, there are clinical reports of a lack of correlation between subarachnoid blood location and clearance rate and vasospasm. 6 Thus, an important scientific tenet that remained to be proven clinically and that was proven in this study is whether vasospasm is independently associated with the volume, duration of presence, and density of subarachnoid blood clot.
Extent and Volume of SAH
Takemae and colleagues 38 and Fisher, et al., 12 recognized that the volume of subarachnoid clot visible on a CT scan obtained shortly after SAH could be used to predict the development of vasospasm. These early studies established the principle of the dependence of vasospasm on initial clot volume and generated the Fisher scale. A relationship between the amount and location of subarachnoid clot and vasospasm as assessed using various clinical, angiographic, and TCD criteria has been confirmed in almost all subsequent investigations. 2, 7, 8, 14, 15, 17, 19, 31, 34, 36, 38 In some studies, however, investigators have not been able to demonstrate such a relationship 6 or have noted only a relatively weak correlation. 15 Although there are several possible reasons for this, the results of our study indicate that other factors, such as clot clearance rate and density, need to be taken into account.
Broderick and colleagues 3 used analysis of digitized CT scans to measure the volume of subarachnoid blood in patients with aneurysmal SAH. The mean volume of SAH was 21 Ϯ 22 ml and served as a powerful predictor of mortality rates in multivariate analysis, whereas the Fisher scale
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Clot volume and clearance rate: independent predictors of vasospasm 259 was not. The relationship of SAH to vasospasm was not studied. Friedman, et al., 14 reported quantification of SAH volumes, noting that all patients with SAH volumes greater than 20 ml experienced severe delayed ischemic deficits. These results are different from those of our study, in which some patients with high volumes of clotting did not suffer vasospasm, probably because the clot was cleared away quickly in these cases. Scatterplots of clot volumes compared with clearance show that these two variables are not directly correlated and that vasospasm occurs in most patients with large clot volumes, although some are spared as a result of rapid clot clearance. Conversely, some patients experience vasospasm due to the persistence of relatively low volumes of clot.
Clot Clearance
The role of clot clearance, accomplished surgically or with intrathecal fibrinolytic agents, in preventing vasospasm has been recognized experimentally 11, 32 and clinically. 10, 20, 24, 40 Kistler and colleagues 26 recognized that rapid spontaneous clearance of subarachnoid clot sometimes meant that a patient categorized as Fisher Grade 3 did not experience vasospasm. Other investigators have suggested that persistence of clot may be important in determining whether vasospasm develops. 19, 39 Since then it has been suggested that larger volumes of clot clear more slowly; 35 however, the results of our study are important because multivariate and quantitative analysis showed that clot density and the rate of clot clearance contribute independently to vasospasm.
Clot Density
Suzuki, et al., 37 noted that Hounsfield values higher than 60 on CT scans taken within 24 hours of aneurysmal SAH were associated with vasospasm. In addition, persistence of high values was associated with vasospasm compared with findings in patients with lower Hounsfield values and with those whose values dropped quickly. Clot volume and clearance rates were not accounted for, and vasospasm was diagnosed simply based on rapid loss of consciousness and/ or motor disturbance 4 to 14 days post-SAH. In their study Suzuki, et al., report that clot density is an important additional independent predictor of vasospasm.
Limitations of the Study
In this study we measured basal cisternal SAH and not the total volume of SAH that would include the clot over the convexities and some clot in the posterior fossa. It has been shown previously that basal volumes are important in predicting vasospasm and that the convexity SAH can be ignored. 13, 14 Other factors may be associated with vasospasm, including IVH. 8, 18 We did not quantify IVH but classification based on a commonly used qualitative scale did not demonstrate significance in multivariate analysis, likely because of the small number of patients examined in this study and the relatively weaker role of IVH in contributing to vasospasm. Most of the patients in the study underwent surgery to clip ruptured aneurysms. Although no specific effort was made to evacuate subarachnoid clot of aneurysms surgically other than in the cisterns that needed to be opened for clip occlusion of aneurysms, it must be stated that the clot clearance rates noted therefore may not reflect the natural history of clot clearance. Clearance rates after endovascular treatment may also be different. Surgery has no effect on vasospasm per se 29 and does not alter the fundamental conclusions about the roles of clot volume, clearance, and density on the development of vasospasm. The day on which the second CT scan was obtained was variable. Clot clearance was calculated as a percentage change per day, although in the absence of multiple CT scans for each patient it is impossible to derive the function that best describes clot clearance in any one patient. Our results indicate, however, that the function differs between patients with and without vasospasm. Finally, because this is a retrospective study there is variability, in addition to other factors mentioned earlier, in the facilities where initial CT scans were performed and in the methods used to diagnose vasospasm. Therefore, it would be optimal to develop software to allow measurement of the aforementioned parameters easily at the CT workstation. Such software would increase the utility of the method and facilitate performance of a prospective study to confirm or modify the findings described here.
